This Event has Passed
Monday, December 02, 2019 - 8:00 AM
to Tuesday, December 03, 2019 - 5:00 PM
8:00 AM - 5:00 PM See all dates and Times
https://go.evvnt.com/507428-0?pid=2809
The Summit provides a platform for you to share your collecting and reporting strategies while increasing your understanding of the best practices in clinical trial monitoring from industry leaders. After this comprehensive two-day event, you will be able to return to work armed with the necessary tools and techniques you need to effectively measure and improve your clinical trials.
Top Five Reasons to Attend
*Develop a greater understanding of clinical metrics and how than can be used to improve site efficiency
*Discover new tools and methodologies to boost performance metric analytics and quality
*Uncover innovative techniques that lead to proactive and comprehensive strategies for monitoring sites and decreasing risk through groundbreaking case studies and innovative sessions on optimizing your metrics tools
*Increase your preparedness for FDA inspections by understanding guidelines and learn strategies for compliance
*Enhance your understanding of the key data your site should measure and what can be done to improve the collection of it
Who Should Attend
This conference is designed for representatives from pharmaceutical and biotech companies, clinical research sites, and academic research organizations with responsibilities in the following areas:
URLs:
Brochure https://go.evvnt.com/507428-2?pid=2809
Booking https://go.evvnt.com/507428-3?pid=2809
Prices:
Early Bird: USD 1895.0,
Standard Price: USD 2195.0,
Onsite Price: USD 2295.0
Speakers:
Sharon Brower, CQA Director, Clinical Training, Process and Continuous Improvement, Global Clinical Operations, BRISTOL-MYERS SQUIBB, Priya Chaturvedi, Ph.D. Executive Director, Quality Assurance-Head Vaccines and ID, MERCK, Leesa Gentry Senior Vice President, Global Clinical Operations and Program Management, EVOTEC (US), INC., David Hamilton Associate Director, Clinical Development and Analytics, Strategy and Operations, NOVARTIS, Tim Koch Global Head of Clinical Analytics, NOVARTIS PHARMACEUTICALS CORPORATION, Sheri Kuss Director, Clinical Quality Lead, PFIZER, Faye O’Brien Director, Performance and Metrics, ASTRAZENECA , Jonathan Rowe, Ph.D., M.S., M.A. Executive Director, Head of Clinical Development Quality Performance and Risk Management, PFIZER, Mayuri Trehan Associate Director, CELGENE, Alec Vardy Executive Director, Clinical Data Management, JAZZ PHARMACEUTICALS
Top Five Reasons to Attend
*Develop a greater understanding of clinical metrics and how than can be used to improve site efficiency
*Discover new tools and methodologies to boost performance metric analytics and quality
*Uncover innovative techniques that lead to proactive and comprehensive strategies for monitoring sites and decreasing risk through groundbreaking case studies and innovative sessions on optimizing your metrics tools
*Increase your preparedness for FDA inspections by understanding guidelines and learn strategies for compliance
*Enhance your understanding of the key data your site should measure and what can be done to improve the collection of it
Who Should Attend
This conference is designed for representatives from pharmaceutical and biotech companies, clinical research sites, and academic research organizations with responsibilities in the following areas:
URLs:
Brochure https://go.evvnt.com/507428-2?pid=2809
Booking https://go.evvnt.com/507428-3?pid=2809
Prices:
Early Bird: USD 1895.0,
Standard Price: USD 2195.0,
Onsite Price: USD 2295.0
Speakers:
Sharon Brower, CQA Director, Clinical Training, Process and Continuous Improvement, Global Clinical Operations, BRISTOL-MYERS SQUIBB, Priya Chaturvedi, Ph.D. Executive Director, Quality Assurance-Head Vaccines and ID, MERCK, Leesa Gentry Senior Vice President, Global Clinical Operations and Program Management, EVOTEC (US), INC., David Hamilton Associate Director, Clinical Development and Analytics, Strategy and Operations, NOVARTIS, Tim Koch Global Head of Clinical Analytics, NOVARTIS PHARMACEUTICALS CORPORATION, Sheri Kuss Director, Clinical Quality Lead, PFIZER, Faye O’Brien Director, Performance and Metrics, ASTRAZENECA , Jonathan Rowe, Ph.D., M.S., M.A. Executive Director, Head of Clinical Development Quality Performance and Risk Management, PFIZER, Mayuri Trehan Associate Director, CELGENE, Alec Vardy Executive Director, Clinical Data Management, JAZZ PHARMACEUTICALS
